本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enliven Treateutics

20.51
+0.66003.32%
盘后20.510.00000.00%17:43 EDT
成交量:22.12万
成交额:452.71万
市值:10.05亿
市盈率:-10.84
高:20.79
开:19.95
低:19.65
收:19.85
数据加载中...
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/27

SEC问询函

Form CORRESP - Correspondence
2024/04/19

SEC问询函

Form CORRESP - Correspondence
2024/04/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

重要事件披露

Form 8-K - Current report